Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity

被引:59
作者
Earnest, James T. [1 ]
Basore, Katherine [2 ]
Roy, Vicky [3 ,4 ]
Bailey, Adam L. [2 ]
Wang, David [2 ,5 ]
Alter, Gaht [3 ,4 ]
Fremont, Daved H. [2 ,5 ,6 ]
Diamond, Michael S. [1 ,2 ,5 ,7 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[3] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
MONOCLONAL-ANTIBODIES; SINDBIS VIRUS; GLYCOPROTEIN ORGANIZATION; ANTIINFLAMMATORY ACTIVITY; HUMAN-IGG; IN-VIVO; RECEPTOR; ALPHAVIRUS; EPITOPE; BRAZIL;
D O I
10.1084/jem.20190736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite causing outbreaks of fever and arthritis in multiple countries, no countermeasures exist against Mayaro virus (MAYV), an emerging mosquito-transmitted alphavirus. We generated 18 neutralizing mAbs against MAYV, 11 of which had "elite" activity that inhibited infection with EC50 values of <10 ng/ml. Antibodies with the greatest inhibitory capacity in cell culture mapped to epitopes near the fusion peptide of El and in domain B of the E2 glycoproteins. Unexpectedly, many of the elite neutralizing mAbs failed to prevent MAW infection and disease in vivo. Instead, the most protective mAbs bound viral antigen on the cell surface with high avidity and promoted specific Fc effector functions, including phagocytosis by neutrophils and monocytes. In subclass switching studies, murine IgG2a and humanized IgG1 mAb variants controlled infection better than murine IgG1 and humanized IgGl-N297Q variants. An optimally protective antibody response to MAYV and possibly other alphaviruses may require tandem virus neutralization by the Fab moiety and effector functions of the Fc region.
引用
收藏
页码:2282 / 2301
页数:20
相关论文
共 55 条
  • [41] INACTIVATED MAYARO VACCINE PRODUCED IN HUMAN DIPLOID CELL-CULTURES
    ROBINSON, DM
    MCMANUS, AT
    COLE, FE
    PEDERSEN, CE
    [J]. MILITARY MEDICINE, 1976, 141 (03) : 163 - 166
  • [42] Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
    Saphire, Erica Ollmann
    Schendel, Sharon L.
    Fusco, Marnie L.
    Gangavarapu, Karthik
    Gunn, Bronwyn M.
    Wec, Anna Z.
    Halfmann, Peter J.
    Brannan, Jennifer M.
    Herbert, Andrew S.
    Qiu, Xiangguo
    Wagh, Kshitij
    He, Shihua
    Giorgi, Elena E.
    Theiler, James
    Pommert, Kathleen B. J.
    Krause, Tyler B.
    Turner, Hannah L.
    Murin, Charles D.
    Pallesen, Jesper
    Davidson, Edgar
    Ahmed, Rafi
    Aman, M. Javad
    Bukreyev, Alexander
    Burton, Dennis R.
    Crowe, James E., Jr.
    Davis, Carl W.
    Georgiou, George
    Krammer, Florian
    Kyratsous, Christos A.
    Lai, Jonathan R.
    Nykiforuk, Cory
    Pauly, Michael H.
    Rijal, Pramila
    Takada, Ayato
    Townsend, Alain R.
    Volchkov, Viktor
    Walker, Laura M.
    Wang, Cheng-I.
    Zeitlin, Larry
    Doranz, Benjamin J.
    Ward, Andrew B.
    Korber, Bette
    Kobinger, Gary P.
    Andersen, Kristian G.
    Kawaoka, Yoshihiro
    Alter, Galit
    Chandran, Kartik
    Dye, John M.
    [J]. CELL, 2018, 174 (04) : 938 - +
  • [43] NON-NEUTRALIZING MONOCLONAL-ANTIBODIES CAN PREVENT LETHAL ALPHAVIRUS ENCEPHALITIS
    SCHMALJOHN, AL
    JOHNSON, ED
    DALRYMPLE, JM
    COLE, GA
    [J]. NATURE, 1982, 297 (5861) : 70 - 72
  • [44] Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection
    Sheehan, Kathleen C. F.
    Lai, Koon Siew
    Dunn, Gavin P.
    Bruce, Allen T.
    Diamond, Mark S.
    Heutel, Jennifer D.
    Dungo-Arthur, Corazon
    Carrero, Javier A.
    White, J. Michael
    Hertzog, Paul J.
    Schreiber, Robert D.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2006, 26 (11) : 804 - 819
  • [45] Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus
    Smith, Scott A.
    Silva, Laurie A.
    Fox, Julie M.
    Flyak, Andrew I.
    Kose, Nurgun
    Sapparapu, Gopal
    Khomadiak, Solomiia
    Ashbrook, Alison W.
    Kahle, Kristen M.
    Fong, Rachel H.
    Swayne, Sherri
    Doranz, Benjamin J.
    McGee, Charles E.
    Heise, Mark T.
    Pal, Pankaj
    Brien, James D.
    Austin, S. Kyle
    Diamond, Michael S.
    Dermody, Terence S.
    Crowe, James E., Jr.
    [J]. CELL HOST & MICROBE, 2015, 18 (01) : 86 - 95
  • [46] Smith V., 2018, Journal of Machine Learning Research, V18, P1
  • [47] TAO MH, 1989, J IMMUNOL, V143, P2595
  • [48] A single mutation in chikungunya virus affects vector specificity and epidemic potential
    Tsetsarkin, Konstantin A.
    Vanlandingham, Dana L.
    Mcgee, Charles E.
    Higgs, Stephen
    [J]. PLOS PATHOGENS, 2007, 3 (12) : 1895 - 1906
  • [49] Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms
    Vogt, Matthew R.
    Dowd, Kimberly A.
    Engle, Michael
    Tesh, Robert B.
    Johnson, Syd
    Pierson, Theodore C.
    Diamond, Michael S.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (22) : 11567 - 11580
  • [50] Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
    Voss, James E.
    Vaney, Marie-Christine
    Duquerroy, Stephane
    Vonrhein, Clemens
    Girard-Blanc, Christine
    Crublet, Elodie
    Thompson, Andrew
    Bricogne, Gerard
    Rey, Felix A.
    [J]. NATURE, 2010, 468 (7324) : 709 - U137